
Chuck Y. Mah
Examiner (ID: 13799, Phone: (571)272-7059 , Office: P/3677 )
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3209, 3205, 3677, 3626, 3676 |
| Total Applications | 4008 |
| Issued Applications | 3305 |
| Pending Applications | 173 |
| Abandoned Applications | 569 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10435798
[patent_doc_number] => 20150320810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'NON-REPLICATING VIRUS-DERIVED PARTICLES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/654259
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 13003
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654259
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654259 | Non-replicating virus-derived particles and uses thereof | Dec 19, 2013 | Issued |
Array
(
[id] => 9424596
[patent_doc_number] => 20140109247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'RAT EMBRYONIC STEM CELL'
[patent_app_type] => utility
[patent_app_number] => 14/132969
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18450
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132969
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/132969 | Rat embryonic stem cell | Dec 17, 2013 | Issued |
Array
(
[id] => 12409272
[patent_doc_number] => 09970024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => RNA-guided human genome engineering
[patent_app_type] => utility
[patent_app_number] => 14/653144
[patent_app_country] => US
[patent_app_date] => 2013-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 54
[patent_no_of_words] => 9737
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653144
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653144 | RNA-guided human genome engineering | Dec 15, 2013 | Issued |
Array
(
[id] => 13182625
[patent_doc_number] => 10106816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Genomic RNA packaging enhancer element
[patent_app_type] => utility
[patent_app_number] => 14/652335
[patent_app_country] => US
[patent_app_date] => 2013-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 43
[patent_no_of_words] => 17742
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652335
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/652335 | Genomic RNA packaging enhancer element | Dec 15, 2013 | Issued |
Array
(
[id] => 10756967
[patent_doc_number] => 20160103119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/651207
[patent_app_country] => US
[patent_app_date] => 2013-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4538
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651207
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/651207 | PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM | Dec 10, 2013 | Abandoned |
Array
(
[id] => 9397099
[patent_doc_number] => 20140094506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'USE OF LIGHT SENSITIVE GENES'
[patent_app_type] => utility
[patent_app_number] => 14/100236
[patent_app_country] => US
[patent_app_date] => 2013-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2437
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14100236
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/100236 | USE OF LIGHT SENSITIVE GENES | Dec 8, 2013 | Abandoned |
Array
(
[id] => 9396482
[patent_doc_number] => 20140093888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'HIGHLY PURE PLASMID DNA PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/099488
[patent_app_country] => US
[patent_app_date] => 2013-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 44245
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099488
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/099488 | HIGHLY PURE PLASMID DNA PREPARATIONS | Dec 5, 2013 | Abandoned |
Array
(
[id] => 10947045
[patent_doc_number] => 20140350066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/091798
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26971
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091798 | COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS | Nov 26, 2013 | Abandoned |
Array
(
[id] => 13051961
[patent_doc_number] => 10047365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Replicative minicircle vectors with improved expression
[patent_app_type] => utility
[patent_app_number] => 14/432693
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 45744
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432693
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432693 | Replicative minicircle vectors with improved expression | Nov 17, 2013 | Issued |
Array
(
[id] => 9670402
[patent_doc_number] => 20140234265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/082760
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 34232
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14082760
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/082760 | COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS | Nov 17, 2013 | Abandoned |
Array
(
[id] => 9383988
[patent_doc_number] => 20140087470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'REVERSIBLE IMMORTALIZATION'
[patent_app_type] => utility
[patent_app_number] => 14/071039
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7385
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14071039
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/071039 | REVERSIBLE IMMORTALIZATION | Nov 3, 2013 | Abandoned |
Array
(
[id] => 10362120
[patent_doc_number] => 20150247125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'MICRORNAS AND CELLULAR REPROGRAMMING'
[patent_app_type] => utility
[patent_app_number] => 14/439245
[patent_app_country] => US
[patent_app_date] => 2013-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5618
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439245
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439245 | MICRORNAS AND CELLULAR REPROGRAMMING | Oct 31, 2013 | Abandoned |
Array
(
[id] => 10444808
[patent_doc_number] => 20150329821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'METHODS OF DIFFERENTIATING STEM CELLS INTO ONE OR MORE CELL LINEAGES'
[patent_app_type] => utility
[patent_app_number] => 14/437147
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 81
[patent_no_of_words] => 29142
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437147 | METHODS OF DIFFERENTIATING STEM CELLS INTO ONE OR MORE CELL LINEAGES | Oct 20, 2013 | Abandoned |
Array
(
[id] => 9191087
[patent_doc_number] => 20130330402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'ANTINUCLEAR ANTIBODY UTILIZED AS A TARGETING AGENT FOR PHARMACEUTICAL COMPOUNDS USED IN THE TREATMENT OF CANCER AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/970099
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5856
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970099
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/970099 | ANTINUCLEAR ANTIBODY UTILIZED AS A TARGETING AGENT FOR PHARMACEUTICAL COMPOUNDS USED IN THE TREATMENT OF CANCER AND OTHER DISEASES | Aug 18, 2013 | Abandoned |
Array
(
[id] => 10317255
[patent_doc_number] => 20150202258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'Medicament for wound treatment'
[patent_app_type] => utility
[patent_app_number] => 14/415658
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13181
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415658
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/415658 | Medicament for wound treatment | Jul 17, 2013 | Abandoned |
Array
(
[id] => 10176274
[patent_doc_number] => 09206469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Nucleic acid purification'
[patent_app_type] => utility
[patent_app_number] => 13/943986
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 8433
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943986
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/943986 | Nucleic acid purification | Jul 16, 2013 | Issued |
Array
(
[id] => 9805192
[patent_doc_number] => 20150017136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/942191
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 30952
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942191
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/942191 | METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY | Jul 14, 2013 | Abandoned |
Array
(
[id] => 11038831
[patent_doc_number] => 20160235787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'Epitope Spreading Associated with CAR T-Cells'
[patent_app_type] => utility
[patent_app_number] => 14/409798
[patent_app_country] => US
[patent_app_date] => 2013-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18950
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409798 | Epitope Spreading Associated with CAR T-Cells | Jul 11, 2013 | Abandoned |
| 13/936782 | CARRIER PEPTIDE FRAGMENT AND USE THEREOF | Jul 7, 2013 | Abandoned |
Array
(
[id] => 10324416
[patent_doc_number] => 20150209420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/408340
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15388
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408340
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408340 | NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES | Jul 4, 2013 | Abandoned |